SENTA Partners is proud to announce its inclusion on the 2026 Inc. 5000 list, ranking at No. 3684. This prestigious ranking celebrates the fastest-growing private companies in America and is considered one of the nation's most respected benchmarks of entrepreneurial success, honoring companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of their communities.
This is the fourth year in a row that SENTA has been recognized by Inc. Magazine. Backed by Shore Capital Partners, SENTA Partners is committed to partnering with leading physicians to build a premier network of ENT and allergy practices across the U.S.
The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent businesses. SENTA’s inclusion reflects its growth, commitment to clinical excellence, advancements in innovation, and dedication to delivering high-quality, patient-centered care.
“We are honored to be recognized on the Inc. 5000 list for the fourth consecutive year,” said Conor Beardsley, CEO of SENTA Partners. “This achievement reflects the dedication of our physicians, providers, and team members who are united by a shared commitment to delivering exceptional ENT and allergy care. From our clinics to our Support Center, every individual has played a role in driving our growth and leaned into our purpose of helping people breathe better, hear better, live better.”
Since its formation in 2019, SENTA has grown into one of the nation's leading physician-centric ENT and allergy organizations, completing 16 healthcare partnerships and expanding to 1,120 employees, including 220 providers across seven states in the Southern US. SENTA’s growth strategy is rooted in physician leadership, investing in innovation, and maintaining a strong culture of collaboration. By combining clinical autonomy with operational support, SENTA enables its partner practices to thrive in today’s evolving healthcare landscape.
“Every company on the Inc. 5000 has a story of perseverance, smart decision making, and a refusal to sit still,” says Mike Hofman, editor-in-chief of Inc. “Their growth reflects more than strong financial performance–it reflects creativity, resilience, and the customer focus required to build companies that make a lasting impact.”
This year’s Inc. 5000 recognizes a new class of companies redefining what growth looks like. From AI and advanced manufacturing to healthcare, consumer products, and professional services, these businesses are expanding their impact, creating jobs and proving that entrepreneurial ambition continues to fuel the U.S. economy. Among the 5,000 companies on the list, the median three-year revenue growth rate was 130%, and those companies have collectively added more than 627,208 jobs to the U.S. economy over the past three years.
ABOUT INC. AND THE INC. 5000 METHODOLOGY
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. Companies on the 2026 Inc. 5000 are ranked according to percentage revenue growth from 2022 to 2025. To qualify, companies must have been founded and generating revenue by March 31, 2022. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2025. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2022 is $100,000; the minimum for 2025 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. For more information, visit www.inc.com.
ABOUT SENTA PARTNERS
Southern Ear, Nose, Throat and Allergy Physicians (SENTA) is a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region. SENTA provides the highest quality allergy, asthma, immunology, and otolaryngology care leading to better patient outcomes. Founded in 2019 with an investment from Shore Capital Partners, SENTA provides strategic, operational, and administrative support to our ENT and Allergy partner practices, empowering physicians to focus on their patients. SENTA is a four-time honoree on the INC. 5000 list of fastest-growing private companies in America (2023, 2024, 2025, 2026). For additional information on SENTA, please visit www.sentapartners.com.
ABOUT SHORE CAPITAL PARTNERS
Shore Capital, a Chicago-based private equity firm with an office in Nashville, is an investor in lower-middle market companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore’s strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020-2026, Shore received recognition from Inc. Magazine as a 7x Top Founder Friendly Investor and by Pitchbook Research for leading U.S. Private Equity deal volume for the past 10 years, from 2016-2025. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has approximately $17 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. To learn more about Shore Capital Partners, and for more information on these awards and investment platforms, please visit www.shorecp.com.